Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of SLC12A3 mRNA | affects expression | 16483693
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride results in decreased expression of SLC12A3 mRNA | decreases expression | 17805973
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride results in increased expression of SLC12A3 protein | increases expression | 15673309
|
C414690 |
eplerenone |
eplerenone inhibits the reaction [AGT protein results in increased phosphorylation of SLC12A3 protein] | decreases reaction|increases phosphorylation | 20175999
|
D005839 |
Gentamicins |
Gentamicins affects the expression of SLC12A3 protein | affects expression | 16850027
|
D006830 |
Hydralazine |
[Hydralazine co-treated with Valproic Acid] results in increased expression of SLC12A3 mRNA | affects cotreatment|increases expression | 17183730
|
D014635 |
Valproic Acid |
[Hydralazine co-treated with Valproic Acid] results in increased expression of SLC12A3 mRNA | affects cotreatment|increases expression | 17183730
|
C081489 |
valsartan |
valsartan inhibits the reaction [AGT protein results in increased phosphorylation of SLC12A3 protein] | decreases reaction|increases phosphorylation | 20175999
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
3.88 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
4.21 | 19490988 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.95 | 18287403 |
MESH:D058186 |
Acute Kidney Injury |
|
Gentamicins |
4.82 | 11274264 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.68 | 17688650 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.79 | 17497229 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
1.99 | 18177632 17157402 18396377 17507914 18558336 20603192 19232924 17688650 18940202 18316065 18775368 18985861 19460635 15238991 16609825 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
3.20 | 20046352 17594078 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
3.57 | 8888407 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
4.14 | 3786805 16097048 16192424 16124888 15700767 16011737 15673190 16050911 18705752 15721981 10355542 16227642 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
1.85 | 18788625 |
MESH:D006332 |
Cardiomegaly |
|
valsartan |
4.32 | 19597038 |
MESH:D009202 |
Cardiomyopathies |
|
valsartan |
4.61 | 16247790 |
MESH:D002318 |
Cardiovascular Diseases |
|
valsartan |
4.48 | 11230374 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.79 | 20734317 |
MESH:D003324 |
Coronary Artery Disease |
|
valsartan |
3.98 | 17719468 |
MESH:D003384 |
Coxsackievirus Infections |
|
valsartan |
6.24 | 20392896 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
1.90 | 8888407 17688650 16575769 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
valsartan |
4.83 | 11508273 |
MESH:D003928 |
Diabetic Nephropathies |
|
valsartan |
5.04 | 11427623 18630688 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
4.18 | 10092053 2869522 6623471 10915739 11566570 7440962 17522070 21278145 3732212 16227642 15968718 7179309 7120509 15027814 6884620 16177239 9327722 19085960 15998439 3786805 19336974 4309450 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
4.18 | 1733752 19641884 |
MESH:D004362 |
Drug Toxicity |
|
Gentamicins |
4.64 | 11033412 15033597 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
4.35 | 1851702 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
4.51 | 3659116 17275665 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
4.36 | 16628512 3922381 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
3.06 | 20417680 18234410 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.84 | 7562514 6254150 6426943 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.66 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
4.46 | 3659116 |
MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
8.83 | 16045604 15959796 12795759 61145 12631006 19224547 17595544 16239168 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
8.83 | 14986274 19224547 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
5.33 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
4.46 | 18558336 8888407 |
MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
10.49 | 18705752 |
MESH:D005355 |
Fibrosis |
|
valsartan |
10.49 | 16893502 |
MESH:D053579 |
Gitelman Syndrome |
marker/mechanism |
|
| |
MESH:D015432 |
Glomerulonephritis, Membranoproliferative |
|
valsartan |
5.87 | 16928621 |
MESH:D034381 |
Hearing Loss |
|
Gentamicins |
5.13 | 18024279 19130971 17868369 15968427 |
MESH:D006333 |
Heart Failure |
|
valsartan |
4.41 | 19027736 |
MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
3.92 | 19900420 19110552 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
5.26 | 17688650 |
MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
4.93 | 16899240 |
MESH:D053565 |
Hypercalciuria |
|
Gentamicins |
6.10 | 17652376 |
MESH:D006973 |
Hypertension |
|
valsartan |
3.81 | 10903974 12850387 20102058 11427623 18344623 18390891 12692753 16475468 |
MESH:D006974 |
Hypertension, Malignant |
|
valsartan |
6.85 | 11560862 |
MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
4.45 | 15338365 |
MESH:D046110 |
Hypertension, Pregnancy-Induced |
|
Hydralazine |
4.98 | 16612254 |
MESH:D007673 |
Kidney Cortex Necrosis |
|
Gentamicins |
6.17 | 18842672 |
MESH:D007674 |
Kidney Diseases |
|
Gentamicins |
7.48 | 19349640 18289764 17934191 |
MESH:D007674 |
Kidney Diseases |
|
valsartan |
7.48 | 16893502 10903974 12164870 |
MESH:D007683 |
Kidney Tubular Necrosis, Acute |
|
Gentamicins |
5.82 | 11231351 |
MESH:D016773 |
Leishmaniasis, Cutaneous |
|
Gentamicins |
4.69 | 10219319 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
2.19 | 17596541 16294345 |
MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
2.94 | 11408273 16239168 17157831 21278145 11903743 16221502 16943688 17174718 17334410 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
3.02 | 15959796 18395914 18418968 15931870 18472332 15338365 16033810 16192424 14512876 17557913 17976157 13678700 16015684 16248980 15876570 17761835 14724832 18376398 18339082 17525996 17823541 12649538 14620537 17805973 16011737 18251166 15650968 18210741 20821823 15730626 11481614 18187930 18006644 17714472 18420326 12898905 17640975 18412020 12445421 17708605 12609069 17766677 15362042 12958196 12389079 16638106 18395095 15673190 12741479 12632514 17565644 12632512 18277467 12546737 16116963 17631135 15370692 15818738 18054572 17922224 16027843 17481882 15057751 15893842 15996030 17698563 18279442 18705752 12666154 18166357 18429990 12445418 17869086 10355542 18156304 17721639 18472094 14716833 15052691 17944888 18205269 14748882 18317297 16136751 18481824 15123356 16097048 17900296 12667390 15925388 14716496 18263696 12586293 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
valsartan |
3.02 | 16872305 15504291 15619341 |
MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
2.13 | 15720792 16964402 15830285 16246199 17285989 |
MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
4.52 | 15123358 |
MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
3.95 | 16899240 14706259 |
MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
2.30 | 19294768 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
2.77 | 15583823 12014681 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
4.70 | 17228818 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.38 | 18765137 18803445 |
MESH:D009137 |
Muscular Dystrophy, Animal |
|
Gentamicins |
6.72 | 18694830 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
4.31 | 8888407 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
3.30 | 17596541 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
3.30 | 16359493 8888407 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
4.23 | 20603192 |
MESH:D011507 |
Proteinuria |
|
Gentamicins |
11.03 | 15033597 |
MESH:D011507 |
Proteinuria |
|
valsartan |
11.03 | 12164870 18344623 17664856 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.98 | 11422049 12752131 |
MESH:D011658 |
Pulmonary Fibrosis |
|
valsartan |
3.90 | 17241526 |
MESH:D051437 |
Renal Insufficiency |
|
Gentamicins |
5.35 | 17132701 15728788 |
MESH:D012173 |
Retinitis |
|
Gentamicins |
6.72 | 18644591 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
4.48 | 19155313 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.09 | 15737665 19110320 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
2.91 | 15475178 16876388 3137016 14763951 17978042 11738929 11044598 1511512 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
3.99 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.98 | 12833885 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.68 | 17262798 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.92 | 3119515 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
5.00 | 8888407 |
MESH:D020257 |
Ventricular Remodeling |
|
valsartan |
6.09 | 19027736 |
MESH:D015837 |
Vestibular Diseases |
|
Gentamicins |
5.85 | 18776599 |